-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Upgrades Vor Biopharma to Buy, Announces $3 Price Target

Benzinga·06/30/2025 10:55:02
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Vor Biopharma (NASDAQ:VOR) from Neutral to Buy and announces $3 price target.